Difference between revisions of "Team:Tuebingen/Basic Part"

 
(20 intermediate revisions by 5 users not shown)
Line 1: Line 1:
−
{{Tuebingen}}
+
<html lang="en">
−
<html>
+
<head>
 +
    <title> iGEM Tübingen 2017</title>
 +
    <meta charset="utf-8" content="width=device-width, initial-scale=1.0"> <!--damit die ü, ä usw. richtig angezeigt werden-->
 +
    <style>
 +
   
 +
html, body {
 +
    height: 100%;
 +
    width: 100%;
 +
    margin-left: 0px;
 +
    padding: 0;
 +
}
  
 +
Css->
  
−
<h1>Basic Parts</h1>
+
    #ImpressumSponsoren{
 +
            bottom:0px;
 +
            margin-left: 25em;
 +
            margin-bottom: 5em;
 +
            margin-right: 10em;
 +
            text-align: right;
 +
        }
  
−
<p>
+
#BigImageLab{
−
A <b>basic part</b> is a functional unit of DNA that cannot be subdivided into smaller component parts. <a href="http://parts.igem.org/wiki/index.php/Part:BBa_R0051">BBa_R0051</a> is an example of a basic part, a promoter regulated by lambda cl.
+
    padding: 0;
 +
    background-size: cover;
 +
    display: block;
 +
    margin: 0 auto;
 +
    margin-left: 0px;
 +
    margin-top: -2em;
 +
 
 +
    max-height: 66%;
 +
    max-width: 100%;
 +
   
 +
    width: 100%;
 +
    height: 99%;
 +
    border: none;
 +
}
 +
       
 +
       
 +
       
 +
               
 +
#home_logo, #sideMenu { display:none; }
 +
  #sideMenu, #top_title, .patrollink  {display:none;}
 +
  #content { width:100%; padding:0px;  margin-top:-7px; margin-left:0px;}
 +
  body {background-color:white; }
 +
  #bodyContent h1, #bodyContent h2, #bodyContent h3, #bodyContent h4, #bodyContent h5 { margin-bottom: 0px; }
 +
 
 +
       
 +
       
 +
       
 +
       
 +
       
 +
       
 +
    a {
 +
    margin-left: 1.5em;
 +
    font-size: 1.25em;
 +
    padding:0.5em;
 +
    border: 1em;
 +
    margin-top: 0.75em;
 +
}
 +
       
 +
    a:link {
 +
            text-decoration: none;
 +
            color:black;
 +
            background-color: transparent;
 +
        }
 +
       
 +
    a:visited {
 +
            text-decoration: none;
 +
            color:black;
 +
            background-color: transparent;
 +
        }
 +
       
 +
    a:hover{
 +
    background-color: transparent;
 +
    color:grey;
 +
    background-color: transparent;
 +
}
 +
       
 +
div.Hauptnavigation{
 +
    text-align: right;
 +
    word-spacing: 0.5;
 +
   
 +
    top: 0.9em;
 +
    background-color: rgb(240,240,250);
 +
    position: fixed;
 +
    width: 100%;
 +
    height: 2em;
 +
    font-size: 1.4em;
 +
    line-height: 1.6em; 
 +
    text-align: center;
 +
    margin-bottom: 0;
 +
    margin-left: 0px;
 +
 
 +
background: linear-gradient(white, transparent 99%);
 +
}
 +
 
 +
 
 +
 
 +
 
 +
nav.Unternavigation-Team{
 +
  max-width: 20%;
 +
  margin-left:0px;
 +
    margin-right: 1.875em;
 +
    margin-top: 12em;
 +
    padding-left: 2em;
 +
    padding-top: 2em;
 +
    padding-bottom:10em;
 +
    font-size: 0.9em;
 +
    line-height:2.3em;
 +
    left: 0em;
 +
    top: 3.5em;
 +
    bottom: -7em;
 +
    position: sticky; 
 +
background: linear-gradient(90deg,white, transparent 70%);
 +
}
 +
 
 +
 
 +
.anchor {
 +
    display:block;
 +
    padding-top:60px;  <!-- careful-->
 +
    margin-top:-60px;
 +
}
 +
 
 +
.active{
 +
    background-color: transparent;
 +
    color: white;
 +
}
 +
 
 +
 
 +
 
 +
.Grid{
 +
    display: grid;
 +
    grid-template-columns: repeat (6, 1fr);
 +
    grid-template-rows: auto;
 +
    margin-bottom: 5em;
 +
    margin-top: -25em;
 +
 
 +
}
 +
       
 +
        #Fliesstext1{     
 +
            grid-column: 2/4;
 +
            grid-row: 1;
 +
            text-align: justify;
 +
            font-size: 18px;
 +
            margin-left: 20em;
 +
            margin-right: 10em;
 +
}
 +
        #Fliesstext2{     
 +
            grid-column: 2/4;
 +
            grid-row: 2;
 +
            text-align: justify;
 +
            font-size: 18px;
 +
            margin-left: 20em;
 +
            margin-right: 10em;
 +
            margin-top: 1.75em;
 +
}
 +
 +
       
 +
/*table setup*/
 +
table, th, td {
 +
  table-layout: fixed;
 +
  width: 100%;
 +
  margin: auto -5px;
 +
 +
  border: 1px solid black;
 +
  border-collapse: collapse;
 +
  padding: 0px;
 +
  text-align: center;
 +
}   
 +
 
 +
h1{font-weight:light;
 +
font-size: 1.2em;
 +
padding-bottom: 1em;
 +
margin-bottom:2em;
 +
}
 +
h2{font-weight:normal;
 +
font-size:1em;
 +
padding-bottom: 1em;
 +
margin-top:-2em;
 +
}
 +
p{font-weight:lighter;
 +
font-size: 1.5em;
 +
line-height:2em;
 +
 
 +
}
 +
li{font-weight:lighter;
 +
font-size: 0.6em;
 +
}
 +
th{font-weight:200;
 +
font-size:0.8em;
 +
}
 +
td{font-weight:lighter;
 +
font-size:0.8em;
 +
}
 +
 
 +
caption{text-align:left;
 +
    font-size: 0.7em;
 +
    margin-bottom: 0.4em;
 +
}
 +
 
 +
figcaption{
 +
font-weight:lighter;
 +
font-size:0.7em;
 +
margin-top:-0.5em;
 +
}
 +
 
 +
#Bild{
 +
    grid-column-start: 0;
 +
    grid-column-end: 0;
 +
    grid-row: 2;
 +
    width: 50%;
 +
    margin-left: 33em;
 +
    margin-top: 3em;
 +
    border: 1px solid black;
 +
}
 +
       
 +
 
 +
       
 +
    </style>
 +
</head>
 +
   
 +
<body>     
 +
      <div class="Hauptnavigation" >
 +
      <a href="https://2017.igem.org/Team:Tuebingen">
 +
      <img src="https://static.igem.org/mediawiki/2017/thumb/b/bb/T--Tuebingen--TrojHorse.png/293px-T--Tuebingen--TrojHorse.png"
 +
                alt="Logo Trojan Horse"
 +
                style="max-height:70%; max-width:90%;float:left; margin-left: 2.5em;margin-top:2px;"> 
 +
      </a>         
 +
     
 +
 
 +
        <a href="https://2017.igem.org/Team:Tuebingen/Team" style="margin-right:1.5em;">Team</a>
 +
        <a href="https://2017.igem.org/Team:Tuebingen/Inspiration"style="margin-right:1.5em;">Inspiration</a>
 +
        <a href="https://2017.igem.org/Team:Tuebingen/Demonstrate"style="margin-right:1.5em;">Results</a>
 +
        <a href="https://2017.igem.org/Team:Tuebingen/HP"style="margin-right:1.5em;">Human Practice</a>
 +
        <a href="https://2017.igem.org/Team:Tuebingen/Lab"style="margin-right:1.5em;">Lab</a>
 +
        <a href="https://2017.igem.org/Team:Tuebingen/Attributions"style="margin-right:1.5em;">Attributions</a>
 +
      </div>
 +
     
 +
  <div style="max-width:100%;">
 +
  <img src="https://static.igem.org/mediawiki/2017/8/8c/T--Tuebingen--LabTitle.jpg" alt="InterLabBild" id="BigImageLab">
 +
   
 +
  <div  style="position: absolute; text-align:right;
 +
                            margin-bottom: 10%;
 +
                            margin-left: 60%;
 +
                            margin-top:-4em;
 +
                            font-size: 3em;color:white;font-weight:light;letter-spacing: 3px;"> basic parts
 +
            </div> </div>
 +
     
 +
     
 +
      <nav class="Unternavigation-Team">
 +
         
 +
              <a href="#BBa_K2372004">BBa_K2372004 </a> <br>
 +
              <a href="#BBa_K2372000">BBa_K2372000 </a> <br>
 +
              <a href="#BBa_K2372001">BBa_K2372001 </a> <br>
 +
              <a href="#BBa_K2372002">BBa_K2372002 </a> <br>
 +
              <a href="#BBa_K2372003">BBa_K2372003 </a> <br>
 +
              <a href="#BBa_K2372005">BBa_K2372005 </a> <br> 
 +
              <a href="#BBa_K2372006">BBa_K2372006 </a> <br>
 +
       
 +
      </nav>
 +
     
 +
     
 +
     
 +
 +
         
 +
          <div class="Grid">
 +
          <!-- Content der Seite -->
 +
            <div id="Fliesstext1"> 
 +
                <h1 id="Basic Parts">Basic Parts</h1>
 +
 
 +
 
 +
           
 +
 
 +
<p><a href="http://parts.igem.org/Part:BBa_K2372004"id="BBa_K2372004" class="anchor">BBa_K2372004</a>  </p>         
 +
               
 +
                <p> SHV-1 is a β-lactamase that mediates resistance against ꞵ-lactams </p>
 +
 
 +
 
 +
 
 +
               
 +
<p> <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372000"id="BBa_K2372000" class="anchor">BBa_K2372000</a> </p>
 +
               
 +
              <p> CouL is a amide synthetase that catalyzes the bonding of the amide bonds in aminocoumarin antibiotics
 
</p>
 
</p>
  
−
<p>Most genetically-encoded functions have not yet been converted to BioBrick parts. Thus, there are <b>many</b> opportunities to find new, cool, and important genetically encoded functions, and refine and convert the DNA encoding these functions into BioBrick standard biological parts. </p>
+
 
−
<br>
+
−
<h3>Best Basic Part Special Prize</h3>
+
  
−
<p>Most genetically-encoded functions have not yet been converted to BioBrick parts. Thus, there are *many* opportunities to find new, cool, and important genetically encoded functions, and refine and convert the DNA encoding these functions into BioBrick standard biological parts. To be eligible for this award, this part must adhere to <a href="http://parts.igem.org/DNA_Submission">Registry sample submission guidelines</a> and have been sent to the Registry of Standard Biological Parts. If you have a part you wish to nominate your team for this <a href="https://2017.igem.org/Judging/Awards">special prize</a>, make sure you add your part number to your <a href="https://2017.igem.org/Judging/Judging_Form">judging form</a> and delete the box at the top of this page.
 
  
−
<br><br>
+
              <p> <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372001"id="BBa_K2372001" class="anchor">BBa_K2372001</a> </p>
−
<b>Please note:</b> Judges will only look at the first part number you list, so please only enter ONE (1) part number in the judging form for this prize. </p>
+
−
<br>
+
  
 +
               
 +
              <p> CloL is a amide synthetase that catalyzes the bonding of the amide bonds in aminocoumarin antibiotics
 +
</p>
  
  
−
<div class="highlight">
+
 
−
<h4>Note</h4>
+
<p> <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372002"id="BBa_K2372002" class="anchor">BBa_K2372002</a> </strong> </p>
−
<p>This page should list all the basic parts your team has made during your project. You must add all characterization information for your parts on the Registry. You should not put characterization information on this page. Remember judges will only look at the first part in the list for the Best Basic Part award, so put your best part first!</p>
+
               
 +
              <p> β-lactam synthetase (BLS) catalyzes the formation of the β-lactam ring of clavulanic acid
 +
</p>
 +
 
 +
 
 +
 
 +
<p> <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372003"id="BBa_K2372003" class="anchor">BBa_K2372003</a> </strong> </p> 
 +
 
 +
               
 +
              <p> The BLS mutant is a rationally designed mutant of the β-lactam synthetase
 +
</p>
 +
 
 +
 
 +
<p> <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372005"id="BBa_K2372005" class="anchor">BBa_K2372005</a>  </p>
 +
               
 +
              <p> Gyrase B (GyrB)is a type II topoisomerase
 +
</p>
 +
 
 +
 +
<p>  <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372006"id="BBa_K2372006" class="anchor">BBa_K2372006</a>  </p>
 +
               
 +
              <p> Gyrase B (GyrB)is a type II topoisomerase
 +
</p>
 +
 
 +
 +
 
 +
 
 +
 
 +
 
 +
<div id="ImpressumSponsoren">
 +
      <img src="https://static.igem.org/mediawiki/2017/5/58/T%C3%BCbingen_Qiagen-Logo.jpeg" id="Quiagen" width=70px>  <img src="https://static.igem.org/mediawiki/2017/1/1c/T%C3%BCbingen_Roth-Logo.jpeg" id="Roth" width=70px>  <img src="https://static.igem.org/mediawiki/2017/d/d8/TuebingenZymoLogo.jpeg" width=150px>  <img src="https://static.igem.org/mediawiki/2017/5/5b/T%C3%BCbingen_Eurofins-Logo.png" id="eurofins" width=150px>    <img src="https://static.igem.org/mediawiki/2017/e/e4/GATCTuebingen.png" id="GATC" width=150px>  <img src="https://static.igem.org/mediawiki/2017/4/49/T%C3%BCbingen_NEB-Logo.jpeg" id="BioLabs" width=150px><br><img src="https://static.igem.org/mediawiki/2017/7/7c/T%C3%BCbingen_Greiner-Logo.jpeg" id="Greiner" width=150px>  <img src="https://static.igem.org/mediawiki/2017/b/bf/T%C3%BCbingen_Agilent-Logo.jpeg" id="Agilent" width=150px>  <img src="https://static.igem.org/mediawiki/2017/0/01/T%C3%BCbingen_abcr-Logo.png" id="abcr" width=150px>  <img src="https://static.igem.org/mediawiki/2017/5/59/MicrosynthTuebingen.png" width=150px>  <img src="https://static.igem.org/mediawiki/2017/8/8b/Eppendorftuebingen.png" width=150px>
 +
        <div> <p> &copy; iGEM Team Tuebingen 2017</p></div>
  
  
 
</div>
 
</div>
 +
 
 +
  
  
 +
</body>
 
</html>
 
</html>

Latest revision as of 12:38, 12 December 2017

iGEM Tübingen 2017

Logo Trojan Horse Team Inspiration Results Human Practice Lab Attributions
InterLabBild
basic parts

Basic Parts

BBa_K2372004

SHV-1 is a β-lactamase that mediates resistance against ꞵ-lactams

BBa_K2372000

CouL is a amide synthetase that catalyzes the bonding of the amide bonds in aminocoumarin antibiotics

BBa_K2372001

CloL is a amide synthetase that catalyzes the bonding of the amide bonds in aminocoumarin antibiotics

BBa_K2372002

β-lactam synthetase (BLS) catalyzes the formation of the β-lactam ring of clavulanic acid

BBa_K2372003

The BLS mutant is a rationally designed mutant of the β-lactam synthetase

BBa_K2372005

Gyrase B (GyrB)is a type II topoisomerase

BBa_K2372006

Gyrase B (GyrB)is a type II topoisomerase


© iGEM Team Tuebingen 2017